What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review

Pain Practice

Volumn 9, Issue 6, 2009, Pages 468-479

  Rauck, Richard L ^a  

^a Center for Clinical Research   (United States)

Author keywords

Chronic noncancer pain; Extended release morphine; Long acting opioid; Pharmacokinetics

Indexed keywords

ALFENTANIL; COCODAMOL; CODEINE; DESIPRAMINE; FENTANYL; GABAPENTIN; HYDROMORPHONE; LIDOCAINE; LONG ACTING DRUG; METHADONE; MORPHINE; MORPHINE SULFATE; NORTRIPTYLINE; OPIATE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; OXYMORPHONE; PARACETAMOL; PARACETAMOL PLUS TRAMADOL; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SHORT ACTING DRUG; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT;

ANALGESIA; CANCER PAIN; CHRONIC PAIN; CONCENTRATION RESPONSE; CONFUSION; CONSTIPATION; DIABETIC NEUROPATHY; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; HUMAN; LOW BACK PAIN; NAUSEA; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT COMPLIANCE; POSTHERPETIC NEURALGIA; PRESCRIPTION; PRURITUS; QUALITY OF LIFE; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SLEEP DISORDER; SUSTAINED RELEASE FORMULATION; UNSPECIFIED SIDE EFFECT; VOMITING; XEROSTOMIA; BLOOD; CHRONIC DISEASE; DRUG ADMINISTRATION; FACTUAL DATABASE; METHODOLOGY; PAIN; PAIN ASSESSMENT; STATISTICS; TIME;

ANALGESICS; ANALGESICS, OPIOID; CHRONIC DISEASE; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; HUMANS; PAIN; PAIN MEASUREMENT; TIME FACTORS;

EID: 74049099791     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2009.00320.x     Document Type: Review

References (67)

1. Rashbaum IG, Sarno JE. Psychosomatic concepts in chronic pain. Arch Phys Med Rehabil 2003, 84(1):S76-S80. suppl, quiz S81-S82
2. Miaskowski C. Recent advances in understanding pain mechanisms provide future directions for pain management. Oncol Nurs Forum 2004, 31(4):S25-S35. suppl
3. Health, United States, 2006: With Chartbook on Trends in the Health of Americans 2006, National Center for Health Statistics, Hyattsville, MD, US Department of Health and Human Services
4. Brunton S. Approach to assessment and diagnosis of chronic pain. J Fam Pract 2004, 53(10):S3-S10. suppl
5. Siddall PJ, Cousins MJ. Persistent pain as a disease entity: implications for clinical management. Anesth Analg 2004, 99:510-520.
6. Tang NK, Wright KJ, Salkovskis PM. Prevalence and correlates of clinical insomnia co-occurring with chronic back pain. J Sleep Res 2007, 16:85-95.
7. van der Waal JM, Terwee CB, van der Windt DA, Bouter LM, Dekker J. Health-related and overall quality of life of patients with chronic hip and knee complaints in general practice. Qual Life Res 2005, 14:795-803.
8. Chiu YH, Silman AJ, Macfarlane GJ. Poor sleep and depression are independently associated with a reduced pain threshold. Results of a population based study. Pain 2005, 115:316-321.
9. The use of opioids for the treatment of chronic. Pain 1997, American Academy of Pain Medicine
10. Trescot AM, Boswell MV, Atluri SL. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006, 9:1-39.
11. McCarberg BH, Barkin RL. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther 2001, 8:181-186.
12. Gourlay GK. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine. Clin Pharmacokinet 1998, 35:173-190.
13. Ferrell B, Wisdom C, Wenzl C, Brown J. Effects of controlled-released morphine on quality of life for cancer pain. Oncol Nurs Forum 1989, 16:521-526.
14. Hale M, Speight K, Harsanyi Z. Efficacy of 12 hourly controlled-release codeine compared with as required dosing of acetaminophen plus codeine in patients with chronic low back pain. Pain Res Manage 1997, 2:33-38.
15. Caldwell JR, Hale ME, Boyd RE. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999, 26:862-869.
16. Hale ME, Fleischmann R, Salzman R. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain. Clin J Pain 1999, 15:179-183.
17. Bodalia B, McDonald CJ, Smith KJ, O'Brien C, Cousens L. A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules. J Pain Symptom Manage 2003, 25:142-149.
18. Adler L, McDonald C, O'Brien C, Wilson M. A comparison of once-daily tramadol with normal release tramadol in the treatment of pain in osteoarthritis. J Rheumatol 2002, 29:2196-2199.
19. Salzman RT, Roberts MS, Wild J, Fabian C, Reder RF, Goldenheim PD. Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control? J Pain Symptom Manage 1999, 18:271-279.
20. Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 1986, 25:297-312.
21. Hill HF, Chapman CR, Saeger LS. Steady-state infusions of opioids in human. II. Concentration-effect relationships and therapeutic margins. Pain 1990, 43:69-79.
22. Hagen NA, Thirlwell M, Eisenhoffer J, Quigley P, Harsanyi Z, Darke A. Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain. J Pain Symptom Manage 2005, 29:80-90.
23. Klepstad P, Kaasa S, Jystad A, Hval B, Borchgrevink PC. Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial. Pain 2003, 101:193-198.
24. Arkinstall WW, Goughnour BR, White JA, Stewart JH. Control of severe pain with sustained-release morphine tablets v. oral morphine solution. CMAJ 1989, 140:661-657.
25. Langford R, McKenna F, Ratcliffe S, Vojtassak J, Richarz U. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial. Arthritis Rheum 2006, 54:1829-1837.
26. Caldwell JR, Rapoport RJ, Davis JC. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002, 23:278-291.
27. Markenson JA, Croft J, Zhang PG, Richards P. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005, 21:524-535.
28. Kivitz A, Ma C, Ahdieh H, Galer BS. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006, 28:352-364.
29. Kjaersgaard-Andersen P, Nafei A, Skov O. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study. Pain 1990, 43:309-318.
30. Matsumoto AK, Babul N, Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Med 2005, 6:357-366.
31. Roth SH, Fleischmann RM, Burch FX. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med 2000, 160:853-860.
32. Rauck RL, Bookbinder SA, Bunker TR. A randomized, open-label, multicenter trial comparing once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: improved physical functioning in the ACTION trial. J Opioid Manag 2007, 3:35-43.
33. Rauck RL, Bookbinder SA, Bunker TR. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manag 2006, 2:155-166.
34. Rauck RL, Bookbinder SA, Bunker TR. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. J Opioid Manag 2006, 2:331-323.
35. Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain 2005, 6:21-28.
36. Allan L, Richarz U, Simpson K, Slappendel R. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain. Spine 2005, 30:2484-2490.
37. Mullican WS, Lacy JR. Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial. Clin Ther 2001, 23:1429-1445.
38. Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N. Analgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol 2004, 31:2454-2463.
39. Ruoff GE, Rosenthal N, Jordan D, Karim R, Kamin M. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther 2003, 25:1123-1141.
40. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003, 60:927-934.
41. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003, 105:71-78.
42. Harati Y, Gooch C, Swenson M. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998, 50:1842-1846.
43. Harati Y, Gooch C, Swenson M. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications 2000, 14:65-70.
44. Freeman R, Raskin P, Hewitt DJ. Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy. Curr Med Res Opin 2007, 23:147-161.
45. Raja SN, Haythornthwaite JA, Pappagallo M. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002, 59:1015-1021.
46. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991, 41:1024-1028.
47. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998, 50:1837-1841.
48. Amabile CM, Bowman BJ. Overview of oral modified-release opioid products for the management of chronic pain. Ann Pharmacother 2006, 40:1327-1335.
49. Mildh LH, Scheinin H, Kirvela OA. The concentration-effect relationship of the respiratory depressant effects of alfentanil and fentanyl. Anesth Analg 2001, 93:939-946.
50. Fiset P, Cohane C, Browne S, Brand SC, Shafer SL. Biopharmaceutics of a new transdermal fentanyl device. Anesthesiology 1995, 83:459-469.
51. Varvel JR, Shafer SL, Hwang SS, Coen PA, Stanski DR. Absorption characteristics of transdermally administered fentanyl. Anesthesiology 1989, 70:928-934.
52. Martell BA, O'Connor PG, Kerns RD. Systematic review. Opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007, 146:116-127.
53. Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007, 147:505-514.
54. Jensen TS, Backonja M, Jimenez S, Tesfaye S, Valensi P, Ziegler D. New perspectives on the management of diabetic peripheral neuropathic pain. Diabetes Vasc Dis Res 2006, 3:108-119.
55. Argoff CE, Backonja MM, Belgrade MJ. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc 2006, 81(4):S12-S25. suppl
56. McCarberg B. Contemporary management of chronic pain disorders. J Fam Pract 2004, 53(10):S11-S22. suppl
57. Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage 2004, 28:396-411.
58. Vallerand AH. The use of long-acting opioids in chronic pain management. Nurs Clin North Am 2003, 38:435-445.
59. Gana TJ, Pascual ML, Fleming RR. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin 2006, 22:1391-1401.
60. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352:1324-1334.
61. Won A, Lapane KL, Vallow S, Schein J, Morris JN, Lipsitz LA. Long-term effects of analgesics in a population of elderly nursing home residents with persistent nonmalignant pain. J Gerontol A Biol Sci Med Sci 2006, 61:165-169.
62. Walker JM, Farney RJ, Rhondeau SM. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007, 3:455-461.
63. Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008, 9:425-432.
64. Kosinski M, Janagap C, Gajria K, Schein J, Freedman J. Pain relief and pain-related sleep disturbance with extended-release tramadol in patients with osteoarthritis. Curr Med Res Opin 2007, 23:1615-1626.
65. Rosenthal M, Moore P, Groves E. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA®): findings from a pilot study. J Opioid Manage 2007, 33:145-154.
66. Passik SD, Kirsh KL. Opioid therapy in patients with a history of substance abuse. CNS Drugs 2004, 18:13-25.
67. Butler SF, Benoit CM, Budman SH. Development and validation of an opioid attractiveness scale: a novel measure of the attractiveness of opioid products to potential abusers. Harm Reduct J 2006, 3:5.